Historical shareholding details of Strategic Advisers U.S. Total Stock holdings in Astrazeneca plc - ADR (AZN)

Monthly changes of Strategic Advisers U.S. Total Stock shareholding in Astrazeneca plc - ADR over the previous months

Month Name Total no. shares held Percent Holding
Jan 31, 2025 Strategic Advisers U.S. Total Stock 479,134 0.02%
Dec 31, 2024 Strategic Advisers U.S. Total Stock 470,651 0.02%
Nov 30, 2024 Strategic Advisers U.S. Total Stock 482,079 0.02%
Oct 31, 2024 Strategic Advisers U.S. Total Stock 313,939 0.01%
Sep 30, 2024 Strategic Advisers U.S. Total Stock 313,939 0.01%
Jul 31, 2024 Strategic Advisers U.S. Total Stock 422,646 0.01%
Jun 30, 2024 Strategic Advisers Large Cap 575,646 0.02%
May 31, 2024 Strategic Advisers Large Cap 575,646 0.02%
Apr 30, 2024 Strategic Advisers Large Cap 532,846 0.02%
Mar 31, 2024 Strategic Advisers Large Cap 474,296 0.02%
Feb 29, 2024 Strategic Advisers Large Cap 557,493 0.02%
Jan 31, 2024 Strategic Advisers Large Cap 387,893 0.01%
Dec 31, 2023 Strategic Advisers Large Cap 399,859 0.01%
Oct 31, 2023 Strategic Advisers® Large Cap 613,869 0.02%
Sep 30, 2023 Strategic Advisers® Large Cap 554,069 0.02%
Jul 31, 2023 Strategic Advisers® Large Cap 518,607 0.02%
Jun 30, 2023 Strategic Advisers® Large Cap 504,280 0.02%
Apr 30, 2023 Strategic Advisers® Large Cap 492,857 0.02%

View all ownership details of Astrazeneca plc - ADR